IL162604A0 - Conformationally constrained c-backbone cyclic peptides - Google Patents
Conformationally constrained c-backbone cyclic peptidesInfo
- Publication number
- IL162604A0 IL162604A0 IL16260403A IL16260403A IL162604A0 IL 162604 A0 IL162604 A0 IL 162604A0 IL 16260403 A IL16260403 A IL 16260403A IL 16260403 A IL16260403 A IL 16260403A IL 162604 A0 IL162604 A0 IL 162604A0
- Authority
- IL
- Israel
- Prior art keywords
- cyclic peptides
- conformationally constrained
- backbone cyclic
- backbone
- conformationally
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34403702P | 2002-01-03 | 2002-01-03 | |
PCT/IL2003/000006 WO2003059933A2 (fr) | 2002-01-03 | 2003-01-02 | Peptides cycliques a squelette carbone presentant une conformation restreinte |
Publications (1)
Publication Number | Publication Date |
---|---|
IL162604A0 true IL162604A0 (en) | 2005-11-20 |
Family
ID=23348766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16260403A IL162604A0 (en) | 2002-01-03 | 2003-01-02 | Conformationally constrained c-backbone cyclic peptides |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050267017A1 (fr) |
EP (1) | EP1468013A4 (fr) |
AU (1) | AU2003207940A1 (fr) |
IL (1) | IL162604A0 (fr) |
WO (1) | WO2003059933A2 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2284459C (fr) | 1999-10-04 | 2012-12-11 | Neokimia Inc. | Synthese combinatoire de bibliotheques de composes macrocycliques utiles pour la decouverte de medicaments |
WO2005123761A1 (fr) * | 2004-06-21 | 2005-12-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Analogues gnrh a squelette cyclise par complexation metallique |
CN101203527A (zh) * | 2005-05-31 | 2008-06-18 | 耶路撒冷希伯来大学伊森姆研究发展公司 | 主链环化的促黑皮质素激素(αMSH)类似物 |
US7981998B2 (en) | 2006-12-14 | 2011-07-19 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
US7960506B2 (en) | 2006-12-14 | 2011-06-14 | Aileron Therapeutics, Inc. | Bis-sulfhydryl macrocyclization systems |
CA2677045C (fr) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Peptides p53 stabilises et utilisations de ceux-ci |
ES2648687T3 (es) | 2007-02-23 | 2018-01-05 | Aileron Therapeutics, Inc. | Péptidos macrocíclicos unidos a triazol |
CA2682174C (fr) | 2007-03-28 | 2021-04-06 | President And Fellows Of Harvard College | Polypeptides cousus |
AU2010204648B2 (en) | 2009-01-14 | 2016-09-01 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CN102712675A (zh) | 2009-09-22 | 2012-10-03 | 爱勒让治疗公司 | 拟肽大环化合物 |
WO2012021876A2 (fr) | 2010-08-13 | 2012-02-16 | Aileron Therapeutics, Inc. | Macrocycles peptidomimétiques |
AU2012267484B2 (en) * | 2011-06-10 | 2017-03-23 | Bioverativ Therapeutics Inc. | Pro-coagulant compounds and methods of use thereof |
CN108929375A (zh) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
ES2817877T3 (es) | 2012-02-15 | 2021-04-08 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
WO2013123267A1 (fr) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Macrocycles peptidomimétiques réticulés par triazole et par thioéther |
JP6526563B2 (ja) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | 二置換アミノ酸ならびにその調製および使用の方法 |
BR112017005736A2 (pt) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | macrociclos peptidomiméticos e formulações dos mesmos |
SG10201902594QA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
CA2979847A1 (fr) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Macrocycles peptidomimetiques et leurs utilisations |
WO2017004548A1 (fr) | 2015-07-01 | 2017-01-05 | Aileron Therapeutics, Inc. | Macrocycles peptidomimétiques |
CN108368161A (zh) | 2015-09-10 | 2018-08-03 | 艾瑞朗医疗公司 | 作为mcl-1调节剂的拟肽大环化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2830442A1 (de) * | 1978-07-11 | 1980-01-24 | Max Planck Gesellschaft | Verfahren zur herstellung von polypeptiden |
IL99628A (en) * | 1991-10-02 | 2004-07-25 | Yissum Res Dev Co | Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them |
US6117974A (en) * | 1991-10-02 | 2000-09-12 | Peptor Limited | Libraries of backbone-cyclized peptidomimetics |
IL109943A (en) * | 1994-06-08 | 2006-08-01 | Develogen Israel Ltd | Conformationally constrained backbone cyclized peptide analogs |
US6407059B1 (en) * | 1994-06-08 | 2002-06-18 | Peptor Limited | Conformationally constrained backbone cyclized peptide analogs |
IL136617A0 (en) * | 1997-12-15 | 2001-06-14 | Peptor Ltd | Branched building units for synthesizing cyclic peptides |
-
2003
- 2003-01-02 EP EP03704944A patent/EP1468013A4/fr not_active Withdrawn
- 2003-01-02 AU AU2003207940A patent/AU2003207940A1/en not_active Abandoned
- 2003-01-02 WO PCT/IL2003/000006 patent/WO2003059933A2/fr not_active Application Discontinuation
- 2003-01-02 IL IL16260403A patent/IL162604A0/xx unknown
-
2005
- 2005-03-21 US US11/085,906 patent/US20050267017A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1468013A4 (fr) | 2005-03-16 |
EP1468013A2 (fr) | 2004-10-20 |
AU2003207940A1 (en) | 2003-07-30 |
US20050267017A1 (en) | 2005-12-01 |
WO2003059933A3 (fr) | 2004-01-15 |
AU2003207940A8 (en) | 2003-07-30 |
WO2003059933A2 (fr) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162604A0 (en) | Conformationally constrained c-backbone cyclic peptides | |
GB2406249B (en) | Cyclic redundancy checks | |
GB0303743D0 (en) | Cyclic reduncancy checks | |
EP1488529A4 (fr) | Controle de redondance cyclique independant | |
AU2003290563A8 (en) | Leptin-related peptides | |
EP1578787A4 (fr) | Nouveaux peptides de chi-conotoxine (-ii) | |
GB0324265D0 (en) | Peptide | |
EP1558628A4 (fr) | Peptides antigeniques | |
AU2003228863A8 (en) | Immunogenic peptides | |
EP1614695A4 (fr) | Polypeptide | |
ZA200600560B (en) | Combined doses | |
GB0202275D0 (en) | Peptide | |
GB0205206D0 (en) | Synthetic peptides | |
GB0210746D0 (en) | Peptide | |
GB0219980D0 (en) | Peptides | |
IL180490A0 (en) | Cyclic peptides | |
EP1362865A4 (fr) | Peptide cyclique | |
GB0326303D0 (en) | Peptides | |
GB0324466D0 (en) | Peptides | |
GB0213246D0 (en) | Peptides | |
GB0224896D0 (en) | Peptides | |
AU154536S (en) | High chair | |
TW586511U (en) | Cap structure | |
GB0207652D0 (en) | Protein structure | |
GB0203883D0 (en) | Peptide |